FDA ELECTROSURGICAL DEVICE GUIDANCE INCLUDES REVISIONS OF INTENDED USE, EtO, WARNINGS PROVISIONS; CLINICAL SECTION NEEDS CLARIFICATION, INDUSTRY REP SAYS
This article was originally published in The Gray Sheet
FDA needs to provide additional guidance on when clinical data should be included in 510(k)s for electrosurgical devices, Robert O'Holla, the industry representative to the agency's General and Plastic Surgery Devices Panel, said at a Sept. 21 meeting of the advisory committee in Gaithersburg, Maryland.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.